If you’re in neuroscience, you’ve probably heard of him. Few people have dipped a hand in as many neuroscience biotechs and government research units as
Although the Centers for Medicare & Medicaid Services (CMS) issued a final rule on prior authorization, there is more that can be done to ease
An early switch to oral antibiotics in patients hospitalized with low-risk Staphylococcus aureus bloodstream infection was noninferior to IV antibiotics, according to the randomized controlled
Doctors may consider blood testing for the endocrine-disrupting chemicals per- and polyfluoroalkyl substances (PFAS) to assess community-wide exposure, the CDC recommended in new guidance this
While one expert called for a “moonshot” to address long COVID, some lawmakers questioned whether federal dollars on such research have been well spent, during
SAN FRANCISCO — Adding the novel anti-TIGIT monoclonal antibody tiragolumab plus atezolizumab (Tecentriq) to standard first-line chemotherapy significantly improved survival for patients with advanced esophageal
While cancer mortality continues to decline, the number of new cases is projected to top 2 million in 2024, according to the American Cancer Society’s
SAN FRANCISCO — A chemoimmunotherapy combination significantly improved long-term survival in advanced esophageal cancer as compared with chemotherapy, follow-up data from a randomized trial showed.
Over-reliance on artificial intelligence (AI) in medicine may lead to a loss of clinical knowledge, a new JAMA viewpoint argued. Agnes Fogo, MD, of Vanderbilt
Many physicians have only a hazy understanding of the FDA’s approval process for new drugs and medical devices, a national survey found. Of 509 physicians